Mutations in CACNA1C, which encodes CaV1.2, result in the pathogenesis of atrial fibrillation [5], ventricular fibrillation [6], hypertrophic cardiomyopathy [7] and ventricular hypertrophy [8]. This evidence concerns the gene CACNA1C and ventricular fibrillation.